These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12089922)

  • 61. Detection of early renal osteodystrophy.
    Eke FU; Winterborn MH; Robertson PW
    Child Nephrol Urol; 1988-1989; 9(1-2):33-7. PubMed ID: 3251619
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Fractures and vertebral bone mineral density in patients with renal osteodystrophy.
    Piraino B; Chen T; Cooperstein L; Segre G; Puschett J
    Clin Nephrol; 1988 Aug; 30(2):57-62. PubMed ID: 3180516
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The assay of the hypocalcemic PTH fragment inhibitor with PTH provides a more accurate assessment of renal osteodystrophy compared to the intact PTH assay.
    Cantor T; Sci B
    Nefrologia; 2003; 23 Suppl 2():69-72. PubMed ID: 12778858
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Relationships between histomorphometric features of bone formation and bone cell characteristics in vitro in renal osteodystrophy.
    Marie PJ; Lomri A; de Vernejoul MC; Morieux C; Graulet AM; Guéris J; Llach F
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1166-73. PubMed ID: 2555383
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Is parathyroid hormone measurement useful for the diagnosis of renal bone disease?
    Drüeke TB
    Kidney Int; 2008 Mar; 73(6):674-6. PubMed ID: 18309349
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ketodiet, physiological calcium intake and native vitamin D improve renal osteodystrophy.
    Lafage MH; Combe C; Fournier A; Aparicio M
    Kidney Int; 1992 Nov; 42(5):1217-25. PubMed ID: 1453606
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Parathyroid hormone (PTH), PTH-derived peptides, and new PTH assays in renal osteodystrophy.
    Goodman WG; Jüppner H; Salusky IB; Sherrard DJ
    Kidney Int; 2003 Jan; 63(1):1-11. PubMed ID: 12472763
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of iPTH values in serum and plasma samples depending on the time and temperature in patients with chronic kidney disease.
    Bencova V; Maris K; Spustova V; Gazovic V; Straussova Z; Cernohorska B; Nemethova D
    Bratisl Lek Listy; 2014; 115(7):439-41. PubMed ID: 25077368
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy: what do we have, what do we need?
    Ferreira A
    Nephrol Dial Transplant; 1998; 13 Suppl 3():29-32. PubMed ID: 9568817
    [No Abstract]   [Full Text] [Related]  

  • 70. Review article: Bone biopsy in chronic kidney disease: patient level end-point or just another test?
    Jorgetti V
    Nephrology (Carlton); 2009 Jun; 14(4):404-7. PubMed ID: 19563382
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of on-line hemodiafiltration with endogenous reinfusion (HFR) on the calcium-phosphorus metabolism: medium-term effects.
    Bolasco PG; Ghezzi PM; Ferrara R; Maxia M; Pinna M; Logias F; Cogoni G; Cadinu F; Ghisu T; Contu B; Casu D; Passaghe M; Pilloni A; Ganadu M; Gazzanelli L
    Int J Artif Organs; 2006 Nov; 29(11):1042-52. PubMed ID: 17160961
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Renal osteodystrophy. Physiopathological and clinical aspects].
    Farinelli A; Bedani PL; Gilli P
    Minerva Urol Nefrol; 1986; 38(4):417-24. PubMed ID: 3589887
    [No Abstract]   [Full Text] [Related]  

  • 73. Technical approach to iliac crest biopsy.
    Hernandez JD; Wesseling K; Pereira R; Gales B; Harrison R; Salusky IB
    Clin J Am Soc Nephrol; 2008 Nov; 3 Suppl 3(Suppl 3):S164-9. PubMed ID: 18988702
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Renal osteodystrophy: diagnostic-therapeutic approach].
    Resić H; Avdić E
    Med Arh; 2006; 60(5):330-2. PubMed ID: 16944742
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evaluation of renal osteodystrophy in the dental clinic by assessment of mandibular and phalangeal cortical indices.
    Massahud BC; Henriques JCG; Jacobs R; Rosa RR; Matai CVB
    Oral Radiol; 2018 May; 34(2):172-178. PubMed ID: 30484132
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Alkaline phosphatase: better than PTH as a marker of cardiovascular and bone disease?
    Lau WL; Kalantar-Zadeh K; Kovesdy CP; Mehrotra R
    Hemodial Int; 2014 Oct; 18(4):720-4. PubMed ID: 25597344
    [No Abstract]   [Full Text] [Related]  

  • 77. A microRNA Approach to Discriminate Cortical Low Bone Turnover in Renal Osteodystrophy.
    Nickolas TL; Chen N; McMahon DJ; Dempster D; Zhou H; Dominguez J; Aponte MA; Sung J; Evenepoel P; D'Haese PC; Mac-Way F; Moyses R; Moe S
    JBMR Plus; 2020 May; 4(5):e10353. PubMed ID: 32490328
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Renal osteodystrophy (I)].
    Covic A; Florea L; Ungureanu C; Covic M
    Rev Med Chir Soc Med Nat Iasi; 2000; 104(3):31-5. PubMed ID: 12089922
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Renal osteodystrophy(II)].
    Covic A; Florea L; Ungureanu C; Covic M
    Rev Med Chir Soc Med Nat Iasi; 2000; 104(4):21-5. PubMed ID: 12089954
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.